Stephen W. Kaldor

Viracept (Nelfinavir Mesylate, AG1343):  A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease

Stephen W. Kaldor, Vincent J. Kalish, Jay F. Davies et al. · Journal of Medicinal Chemistry · 1997 · 617 citations · Full text

Immunology, Antiviral Drug, Nelfinavir Mesylate +17

Discovery of Alogliptin:  A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV

Jun Feng, Zhiyuan Zhang, Michael B. Wallace et al. · Journal of Medicinal Chemistry · 2007 · 399 citations · Full text

Plasma Dpp-4 Activity, Pharmacotherapy, Chemical Biology +17

Total synthesis of the macrolide antibiotic cytovaricin

David A. Evans, Stephen W. Kaldor, Todd K. Jones et al. · Journal of the American Chemical Society · 1990 · 312 citations

Bioorganic Chemistry, Altmetric Attention Score, Antimicrobial Chemotherapy +20

Use of solid supported nucleophiles and electrophiles for the purification of non-peptide small molecule libraries

Stephen W. Kaldor, Miles G. Siegel, James E. Fritz et al. · Tetrahedron Letters · 1996 · 226 citations

Biochemistry, Protein Folding, Natural Sciences +5

Solid phase synthesis of hydantoins using a carbamate linker and a novel cyclization / cleavage step

Bruce A. Dressman, Larry A. Spangle, Stephen W. Kaldor · Tetrahedron Letters · 1996 · 209 citations

Engineering, Heterocyclic, Organic Chemistry +5